Researchers at Rensselaer Polytechnic Institute envision a day when surgeons will benefit from personalized training, rather than sheer practice repetition, thanks to novel neuroimaging and artificial intelligence methodologies. Under this method, surgeons would complete technical tasks while images of their brain activity reveal how well they have mastered critical skills.
TROY, N.Y. — Glioblastomas are complex, fast-growing malignant brain tumors that are made up of various types of cells. Even with aggressive treatment — which often includes surgery, radiation, and chemotherapy — glioblastomas are difficult to treat, leading to an average survival of 11-15 months.
TROY, N.Y. — Improving the detection, diagnosis, and treatment of diseases like cancer will require more detailed, rapid, and agile imaging technology that can show doctors not just what a specific organ looks like, but also what’s happening within the cells that make up those tissues.
TROY, N.Y. — If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor treatment options with unprecedented specificity. An academic-industrial partnership between engineers at Rensselaer Polytechnic Institute, molecular and cellular biologists at Albany Medical College, and engineers at MARS Bioimaging Ltd aims to make this a reality for the treatment of breast cancer through the combination of highly innovative X-ray and optical imaging technologies.
TROY, N.Y. — Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute. The research team’s new technique has the potential to vastly improve the quality and speed of imaging in live subjects and was the focus of an article recently published in Light: Science and Applications, a Nature journal.
Researchers at Rensselaer Polytechnic Institute and Albany Medical Center are working together to develop three-dimensional bioprinting and imaging techniques that will generate and analyze tumor models in the laboratory, with the goal of accelerating the development and optimization of personalized anti-cancer drugs.
A new approach to optical imaging makes it possible to quickly and economically monitor multiple molecular interactions in a large area of living tissue – such as an organ or a small animal; technology that could have applications in medical diagnosis, guided surgery, or pre-clinical drug testing.
Xavier Intes, assistant professor in the Department of Biomedical Engineering at Rensselaer, has won a prestigious Faculty Early Career Development Award from the National Science Foundation.